U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Showing 1 - 10 of 20 results

Status:
US Approved Rx (2024)
First approved in 2014

Class (Stereo):
CHEMICAL (ABSOLUTE)



Apremilast (brand name Otezla) selective inhibitor of phosphodiesterase 4 is used for the treatment of patients with moderate to severe plaque psoriasis. OTEZLA is the first and only PDE4 inhibitor approved for the treatment of plaque psoriasis, a ch...
Status:
US Approved Rx (2020)
First approved in 2012

Class (Stereo):
CHEMICAL (ABSOLUTE)



Tofacitinib is an orally available inhibitor of Janus kinases (JAK), with immunomodulatory and anti-inflammatory activities. Upon administration, tofacitinib binds to JAK and prevents the activation of the JAK-signal transducers and activators of tra...
Status:
US Approved Rx (2021)
First approved in 2010

Class (Stereo):
CHEMICAL (ACHIRAL)



Fingolimod (FTY720) is a sphingosine 1-phosphate receptor modulator indicated and approved for the treatment of relapsing-remitting multiple sclerosis. Fingolimod (trade name Gilenya, Novartis) is metabolized by sphingosine kinase to the active meta...
Status:
US Approved Rx (2021)
First approved in 2009

Class (Stereo):
CHEMICAL (ABSOLUTE)



Everolimus is a derivative of Rapamycin (sirolimus), it is a mTOR inhibitor that binds with high affinity to the FK506 binding protein-12 (FKBP-12), thereby forming a drug complex that inhibits the activation of mTOR. This inhibition reduces the acti...
Status:
US Approved Rx (2019)
First approved in 1999

Class (Stereo):
CHEMICAL (ABSOLUTE)



Sirolimus is the USAN-assigned generic name for the natural product rapamycin. Sirolimus is produced by a strain of Streptomyces hygroscopicus, isolated from a soil sample collected from Rapa Nui commonly known as Easter Island. Although sirolimus wa...
Status:
US Approved Rx (2019)
First approved in 1998

Class (Stereo):
CHEMICAL (ACHIRAL)



Teriflunomide (trade name Aubagio, marketed by Sanofi) is the active metabolite of leflunomide and it acts as an immunomodulatory agent by inhibiting pyrimidine synthesis by blocking the enzyme dihydroorotate dehydrogenase. Teriflunomide was investig...
Status:
US Approved Rx (2024)
First approved in 1995

Class (Stereo):
CHEMICAL (ACHIRAL)



Mycophenolic acid (MPA) possesses antibacterial, antifungal, antiviral, immunosuppressive and anticancer properties. Mycophenolic acid (MPA) is a fungal metabolite that was initially discovered by Bartolomeo Gosio in 1893 as an antibiotic against ant...
Status:
Possibly Marketed Outside US

Class (Stereo):
CHEMICAL (RACEMIC)



Gusperimus is an antibiotic, isolated from cultures of the soil commensal Bacillus laterosporus. It possess immunosuppressive properties and exerts its effect through binding to heat shock proteins Hsp90 and Hsc70. Although initially, the drug was be...
Status:
US Approved Rx (2011)
First approved in 2011

Class:
PROTEIN

Status:
US Approved Rx (2011)
First approved in 2011

Class:
PROTEIN

Showing 1 - 10 of 20 results